Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20857662rdf:typepubmed:Citationlld:pubmed
pubmed-article:20857662lifeskim:mentionsumls-concept:C0026850lld:lifeskim
pubmed-article:20857662lifeskim:mentionsumls-concept:C0002903lld:lifeskim
pubmed-article:20857662lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:20857662lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:20857662pubmed:issue9lld:pubmed
pubmed-article:20857662pubmed:dateCreated2010-9-22lld:pubmed
pubmed-article:20857662pubmed:abstractTextThe muscular dystrophies are inherited myogenic disorders characterized by progressive muscle wasting and weakness of variable distribution and severity. They can be subdivided into several groups, including congenital forms, in accordance with the distribution of predominant muscle weakness: Duchenne/Becker; limb-girdle; Fukuyama type congenital muscular dystrophy; Emery-Dreifus; facioscapulohumeral; oculopharyngeal; myotonic dystrophy, et al. Muscular dystrophies are susceptible to perioperative respiratory, cardiac and other complications, such as rhabdomyolysis. Halogenated inhalational anesthetic agents have been implicated as a cause of acute rhabdomyolysis that resembles malignant hyperthermia. Depolarizing neuromuscular blocking drugs that cause rhabdomyolysis are contraindicated in these patients. Recommendations are proposed for the safe anesthetic management of these patients.lld:pubmed
pubmed-article:20857662pubmed:languagejpnlld:pubmed
pubmed-article:20857662pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20857662pubmed:citationSubsetIMlld:pubmed
pubmed-article:20857662pubmed:statusMEDLINElld:pubmed
pubmed-article:20857662pubmed:monthSeplld:pubmed
pubmed-article:20857662pubmed:issn0021-4892lld:pubmed
pubmed-article:20857662pubmed:authorpubmed-author:SobueKazuyaKlld:pubmed
pubmed-article:20857662pubmed:authorpubmed-author:YamauchiHirok...lld:pubmed
pubmed-article:20857662pubmed:issnTypePrintlld:pubmed
pubmed-article:20857662pubmed:volume59lld:pubmed
pubmed-article:20857662pubmed:ownerNLMlld:pubmed
pubmed-article:20857662pubmed:authorsCompleteYlld:pubmed
pubmed-article:20857662pubmed:pagination1093-5lld:pubmed
pubmed-article:20857662pubmed:meshHeadingpubmed-meshheading:20857662...lld:pubmed
pubmed-article:20857662pubmed:meshHeadingpubmed-meshheading:20857662...lld:pubmed
pubmed-article:20857662pubmed:meshHeadingpubmed-meshheading:20857662...lld:pubmed
pubmed-article:20857662pubmed:meshHeadingpubmed-meshheading:20857662...lld:pubmed
pubmed-article:20857662pubmed:year2010lld:pubmed
pubmed-article:20857662pubmed:articleTitle[Anesthesia preoperative preparation of muscular dystrophy].lld:pubmed
pubmed-article:20857662pubmed:affiliationToyota-Kai Medical Corporation, Kariya Toyota General Hospital, Kariya 448-8505.lld:pubmed
pubmed-article:20857662pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20857662pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:20857662pubmed:publicationTypeReviewlld:pubmed